KR950704286A - 탁산 유도체의 신규한 제조방법, 이로써 얻은 신규한 유도체 및 이를 함유한 조성물(novel method for preparing taxane derivatives, novel dervatvatives thus obtained and compositions containing them) - Google Patents

탁산 유도체의 신규한 제조방법, 이로써 얻은 신규한 유도체 및 이를 함유한 조성물(novel method for preparing taxane derivatives, novel dervatvatives thus obtained and compositions containing them)

Info

Publication number
KR950704286A
KR950704286A KR1019950702091A KR19950702091A KR950704286A KR 950704286 A KR950704286 A KR 950704286A KR 1019950702091 A KR1019950702091 A KR 1019950702091A KR 19950702091 A KR19950702091 A KR 19950702091A KR 950704286 A KR950704286 A KR 950704286A
Authority
KR
South Korea
Prior art keywords
novel
derivatives
compositions containing
pct
taxane derivatives
Prior art date
Application number
KR1019950702091A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950704286A publication Critical patent/KR950704286A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019950702091A 1992-11-23 1995-05-22 탁산 유도체의 신규한 제조방법, 이로써 얻은 신규한 유도체 및 이를 함유한 조성물(novel method for preparing taxane derivatives, novel dervatvatives thus obtained and compositions containing them) KR950704286A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214023A FR2698363B1 (fr) 1992-11-23 1992-11-23 Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
PCT/FR1993/001145 WO1994012484A1 (fr) 1992-11-23 1993-11-22 Nouveau procede de preparation de derives du taxane, nouveaux derives ainsi obtenus et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
KR950704286A true KR950704286A (ko) 1995-11-17

Family

ID=9435782

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702091A KR950704286A (ko) 1992-11-23 1995-05-22 탁산 유도체의 신규한 제조방법, 이로써 얻은 신규한 유도체 및 이를 함유한 조성물(novel method for preparing taxane derivatives, novel dervatvatives thus obtained and compositions containing them)

Country Status (23)

Country Link
US (1) US5606083A (ko)
EP (1) EP0669916B1 (ko)
JP (1) JPH08503486A (ko)
KR (1) KR950704286A (ko)
AT (1) ATE148111T1 (ko)
AU (1) AU680455B2 (ko)
CA (1) CA2149758A1 (ko)
CZ (1) CZ131795A3 (ko)
DE (1) DE69307730T2 (ko)
DK (1) DK0669916T3 (ko)
ES (1) ES2096440T3 (ko)
FI (1) FI952482A (ko)
FR (1) FR2698363B1 (ko)
GR (1) GR3022359T3 (ko)
HU (1) HUT74069A (ko)
NO (1) NO952017D0 (ko)
NZ (1) NZ258144A (ko)
PL (1) PL309037A1 (ko)
RU (1) RU95113421A (ko)
SK (1) SK68195A3 (ko)
TW (1) TW254938B (ko)
WO (1) WO1994012484A1 (ko)
ZA (1) ZA938728B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100400810B1 (ko) * 1995-03-22 2004-05-31 브리스톨-마이어스스퀴브컴파니 옥사졸리딘중간체를사용하는탁산의제조방법

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698582A (en) * 1991-07-08 1997-12-16 Rhone-Poulenc Rorer S.A. Compositions containing taxane derivatives
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5677470A (en) 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
ATE234800T1 (de) 1997-08-21 2003-04-15 Univ Florida State Verfahren zur synthese von taxanen
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
DE60327651D1 (de) * 2002-10-09 2009-06-25 Chatham Biotec Ltd Thio-analoga von paclitaxel und deren vorprodukte
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
FR2986526A1 (fr) * 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100400810B1 (ko) * 1995-03-22 2004-05-31 브리스톨-마이어스스퀴브컴파니 옥사졸리딘중간체를사용하는탁산의제조방법

Also Published As

Publication number Publication date
FR2698363B1 (fr) 1994-12-30
AU680455B2 (en) 1997-07-31
JPH08503486A (ja) 1996-04-16
AU5565994A (en) 1994-06-22
US5606083A (en) 1997-02-25
EP0669916B1 (fr) 1997-01-22
FI952482A0 (fi) 1995-05-22
ZA938728B (en) 1994-06-28
CA2149758A1 (fr) 1994-06-09
ES2096440T3 (es) 1997-03-01
WO1994012484A1 (fr) 1994-06-09
NO952017L (no) 1995-05-22
RU95113421A (ru) 1997-03-20
FR2698363A1 (fr) 1994-05-27
EP0669916A1 (fr) 1995-09-06
PL309037A1 (en) 1995-09-18
FI952482A (fi) 1995-05-24
CZ131795A3 (en) 1995-10-18
DK0669916T3 (da) 1997-02-10
NO952017D0 (no) 1995-05-22
NZ258144A (en) 1996-10-28
ATE148111T1 (de) 1997-02-15
DE69307730D1 (de) 1997-03-06
GR3022359T3 (en) 1997-04-30
HU9501500D0 (en) 1995-07-28
SK68195A3 (en) 1995-10-11
DE69307730T2 (de) 1997-06-05
HUT74069A (en) 1996-10-28
TW254938B (ko) 1995-08-21

Similar Documents

Publication Publication Date Title
KR950704286A (ko) 탁산 유도체의 신규한 제조방법, 이로써 얻은 신규한 유도체 및 이를 함유한 조성물(novel method for preparing taxane derivatives, novel dervatvatives thus obtained and compositions containing them)
RU2329043C2 (ru) Соединения, воздействующие на глюкокиназу
NO951202D0 (no) Fremgangsmåte for fremstilling av taxanderivater
FI951592A0 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
NO953452D0 (no) Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
NO943371D0 (no) Fremgangsmåte for fremstilling av taxanderivater
NO951840L (no) Fremgangsmåte for fremstilling av 1,3-oksazolidin-5-karboksylsyre
MX9706568A (es) Nuevos taxoides, su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid